Weber F, Anlauf M
Eur J Clin Pharmacol. 1985;28(2):139-42. doi: 10.1007/BF00609681.
In order to characterize the beta-adrenoceptor subtype of the venous vessel wall, venous occlusion plethysmograph studies were carried out in 7 healthy volunteers. Venous distensibility (VD) was considered to be a measure of venous tone. Infusion of the beta 1- and beta 2-adrenoceptor agonist isoproterenol (I), of the predominantly beta 2-adrenoceptor agonist fenoterol (F) and of the predominantly beta 1-adrenoceptor agonist dobutamine (D) in increasing doses led to a significant increase in VD by I and F but not by D. Administration of the beta 1-adrenoceptor antagonists betaxolol (B) and metoprolol (M) did not significantly change VD. Neither beta-adrenoceptor antagonist prevented the increase in VD provoked by subsequent administration of I or F. It is concluded that beta-adrenoceptors in the venous vessel wall belong to the beta 2-adrenoceptor subtype.
为了明确静脉血管壁的β-肾上腺素能受体亚型,对7名健康志愿者进行了静脉阻塞体积描记法研究。静脉扩张性(VD)被视为静脉张力的一种度量。以递增剂量输注β1和β2肾上腺素能受体激动剂异丙肾上腺素(I)、主要的β2肾上腺素能受体激动剂非诺特罗(F)以及主要的β1肾上腺素能受体激动剂多巴酚丁胺(D),结果显示I和F可使VD显著增加,而D则无此作用。给予β1肾上腺素能受体拮抗剂倍他洛尔(B)和美托洛尔(M)后,VD无显著变化。两种β-肾上腺素能受体拮抗剂均不能阻止随后给予I或F所引起的VD增加。由此得出结论,静脉血管壁中的β-肾上腺素能受体属于β2肾上腺素能受体亚型。